Incidence of the main cancers in metropolitan France in 2023 and trends since 1990

The estimate comes from the partnership of the Francim registry network, the biostatistics service of the Hospices Civils de Lyon, Santé publique France and INCa. It covers the 19 most frequent cancers (15 in men and 18 in women) and all cancers together, counts invasive tumours only and excludes skin cancers other than melanoma. Incidence for 2023 was projected from registry data observed between 1985 and 2018.

The all-cancer estimate for 2023 is 433,136 new cases, 57 per cent of them in men, at world age-standardised rates of 355 per 100,000 person-years in men and 274 in women; the median age at diagnosis is 70 in men and 68 in women. Since 1990 the all-cancer rate in women has risen by 0.9 per cent a year; in men it rose by 0.3 per cent a year on average, rising until the mid-2000s, then falling and apparently stable since 2012. Changing trends made the 2019 to 2023 projections for prostate and thyroid cancer too uncertain to publish. Combined with the growth and ageing of the population, these rates have roughly doubled the number of new cancers a year since 1990 in both sexes.